A Genome-Wide Synthetic Lethal Screen Identifies Spermidine Synthase as a Target to Enhance Erdafitinib Efficacy in FGFR-Mutant Bladder CancerYanchao Yu, Xingyuan Xiao, Xincheng Gao et al.|Cancer Research|2025Cited by 8
Data from A Genome-Wide Synthetic Lethal Screen Identifies Spermidine Synthase as a Target to Enhance Erdafitinib Efficacy in FGFR-Mutant Bladder CancerYanchao Yu, Xingyuan Xiao, Xincheng Gao et al.|Unknown|2025Cited by 0
Figure S5 from A Genome-Wide Synthetic Lethal Screen Identifies Spermidine Synthase as a Target to Enhance Erdafitinib Efficacy in FGFR-Mutant Bladder CancerYanchao Yu, Xingyuan Xiao, Xincheng Gao et al.|Unknown|2025Cited by 0
Figure S4 from A Genome-Wide Synthetic Lethal Screen Identifies Spermidine Synthase as a Target to Enhance Erdafitinib Efficacy in FGFR-Mutant Bladder CancerYanchao Yu, Xingyuan Xiao, Xincheng Gao et al.|Unknown|2025Cited by 0
Figure S1 from A Genome-Wide Synthetic Lethal Screen Identifies Spermidine Synthase as a Target to Enhance Erdafitinib Efficacy in FGFR-Mutant Bladder CancerYanchao Yu, Xingyuan Xiao, Xincheng Gao et al.|Unknown|2025Cited by 0